Intellectual Property India Publishes Patent Application for 'Oral Formulation Of N-Pyridinyl Acetamide Derivative For Treating Interstitial Lung Disease' Filed by Astrazeneca Ab

MUMBAI, India, June 27 -- Intellectual Property India has published a patent application (202517053878 A) filed by Astrazeneca Ab, Sodertalje, Sweden, on June 3, for 'oral formulation of n-pyridinyl acetamide derivative for treating interstitial lung disease.'

Inventor(s) include Owen, Caroline Ann; Prothon, Susanne; Williams, Michael Lee; Ferrari, Nicola; Wikstrom, Hakan; Sjostrand, Veronika; Fransson, Rebecca; and Chukharkina, Alexandra Pavlovna.

The application for the patent was published on June 27, under issue no. 26/2025.

According to the abstract released by the Intellectual Property India: "The present disclosure relates to oral formulations of an n-pyridinyl acetamide derivative, and the use of such formulations in the treatment of interstitial lung diseases."

The patent application was internationally filed on Nov. 03, 2023, under International application No.PCT/EP2023/080652.

Disclaimer: Curated by HT Syndication.